Glioma, Malignant

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Niraparib In Recurrent IDH 1/2 Gliomas

Imaging of Solid Tumors Using 18F-TRX

Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma

Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Window of Opportunity Study of DSP-0390 in Gliomas

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma